- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- Medica Group LLC
Medica Group LLC
Medica Group LLC is engaged in the localization of a joint Russian-Chinese project for the production of automatic microbiology analyzers on the territory of priority development in Novouralsk. The corresponding document was signed in the management company of the territory of advanced social and economic development (TASED) Atom- TOR. The project of localization of production in Russia was our response to the imposition of sanctions and threats of vital product lack. This project for the production of analyzers and culture vials gives us independence from foreign supplies.
Areas of company activities:
- Laboratory consumables;
- Modern solutions for microbiological laboratories;
- Medical equipment;
Clinical microbiology is an important link in the study of pathogenic features, pathogen diagnosis, rational use of antimicrobials and monitoring of nosocomial infection.
Sepsis is a fatal disease. About 30% of patients are misdiagnosed. This is due to the fact that current detection methods have low specificity and are slow. It takes days to get results, leading doctors to prescribe ineffective antibiotics, which in turn leads to the spread of antibiotic-resistant strains and increased deaths caused by blood infections. Every hour of delay in the use of effective antibiotics reduces survival by 7.6%. The introduction of innovative technologies in microbiological laboratories allows raising diagnostics to a new level, reducing the time for issuing results to 18-24 hours.
Automatic analyzers using advanced technology:
- YUNONA®LABSTAR model for testing the sterility of blood cultures and other biological fluids;
- Vials for blood cultures;
- YUNONA® HK model for identification of microorganisms and determination of sensitivity to antibiotics;
- Reagent kits for identification and sensitivity to antibiotics;
Automation of microbiological laboratories is an increase in the efficiency that directs the diagnosis, treatment and prevention of infectious diseases to obtain a quick and accurate diagnosis.
Medica Group of companies
Phone: +7 (343) 270-75-17
E-mail: medica.group@mail.ru
Website: medicagroup.ru
